Small LDL-P: small LDL subclass particle number): total number nmol/LL). Often is elevated in individuals with high triglycerides and low HDL and is a significant source of CHD risk in many metabolic syndrome and diabetic patients. Small LDL-P <850 nmolJL (<50th percentile) is a reasonable secondary treatment goal for high-risk and moderately high-risk patients. Small LDL-P is lowered effectively by diet and exercise and by combining such agents as niacin or a fihrate with [DL lowering drugs.

Lipids: provides all of the information in a traditional lipid panel.

LDL-C risk categories are those given in NCEP guidelines. The highlighted box indicates the patient’s risk category. The corresponding risk categories (on a percentile equivalence basis) are given for LDL-P. When the patient’s LDL-C and LDL-P risk categories differ, research indicates that LDL-P is the better indicator of risk.

Metabolic Syndrome Markers: reports key traits associated with the metabolic syndrome and increased risk of Type 2 Diabetes Mellitus

LDL Size: average diameter )nm) of the patient’s LDL particles. Large LDL (Pattern A) is associated with lower risk and small LDL (Pattern B) with higher risk of developing CHD and diabetes.

Large I-LDL-P: large HDL subclass particle number (pmolIL). “Higher-risk” values are <4.0 pmolIL (<25th percentile) and “lower risk” values are >9.0 pmolJL (>75th percentile).

Large VLDL-P: large VLDL subclass particle number (nmol/L). “Higher-risk” values are >5.0 nmol/L (>75th percentile) and “lower-risk” values are <0.5 nmol/L (<25th percentile).